Addressing Unmet Needs in Triage Options During Cervical Cancer Screening

Addressing Unmet Needs in Triage Options During Cervical Cancer Screening

Addressing Unmet Needs in Triage Options During Cervical Cancer Screening

Discover why current approaches to CCS triage lead to diagnostic uncertainty and cloud patient management and learn how to counteract these issues.

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Cervical cancer screening (CCS) methods include cytology alone, use of primary high-risk HPV testing alone, and co-testing. Regardless of the screening approach used, effective triage tests are needed to decide who among the presumptive positive women should receive further diagnostic evaluation. Unfortunately, current approaches to triage can complicate matters and the results can be more confusing than constructive.

    Our discussion today will focus on how to address the unmet needs associated with current CCS triage options and the diagnostic benefits provided by p16/Ki-67 dual-staining cytology in CCS triage to alleviate diagnostic uncertainty within clinical practice.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Stephen M. Cohen, MD, FACOG
    SUNY Upstate Medical School
    Syracuse, NY 

    Consulting Fees: AbbVie   

    Thomas C. Wright, Jr., MD
    Professor Emeritus of Pathology and Cell Biology
    Columbia University
    New York, NY
    Enzo Clinical Laboratories
    Farmingdale, NY 

    Consulting Fees: BD, Inovio, Roche Diagnostics

    Reviewers/Content Planners/Authors:

    • Cathy Aubel has nothing to disclose.
    • Sean T. Barrett has nothing to disclose.
    • Barry A. Fiedel, PhD, has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Describe the unmet needs associated with current cervical cancer screening (CCS) triage options.
    • Explain the diagnostic benefits provided by p16/Ki-67 dual-staining cytology in CCS triage to alleviate diagnostic uncertainty.
    • Formulate strategies that maximize the diagnostic benefits of p16/Ki-67 dual-staining cytology within clinical practice.
  • Target Audience

    This activity is designed to meet the educational needs of ob-gyns, nurse practitioners, physician assistants, nurses, and pathologists.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant from Roche Diagnostics.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments


We’re glad to see you’re enjoying Omnia Education…
but how about a more personalized experience?

Register for free